Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline

Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.

i

Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline

11/15/2019
By Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.
Source: American Journal of Respiratory and Critical Care Medicine, Volume 200, Issue 10,

[PDF-1.08 MB]

English

Details You May Also Like

Details:

Personal Author:

Payam Nahid, Sundari R. Mase, Giovanni Battista Migliori et al.
Corporate Authors:

American Cancer Society
Description:

The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on treatment of multidrug-resistant TB (MDR-TB), as well as isoniazid-resistant but rifampin-susceptible TB.
Subjects:

[+]

Drug Monitoring Tuberculosis Tuberculosis, MDR Tuberculosis, Multidrug-Resistant
Source:

American Journal of Respiratory and Critical Care Medicine, Volume 200, Issue 10,
Document Type:

Journal Article
Genre:

Practice Guideline
Place as Subject:

United States
Pages in Document:

p. 93-142
Volume:

200
Issue:

10
Collection(s):

Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
Main Document Checksum:

[+]

urn:sha-512:614450d7a6d879e4ae5b95713a0c7f3e9666103019cd29594a9111a6b1b8f24de9f34e818b61c0529091e875a56887fd73d04180f49f61102cf24fcd72776fa6
Download URL:

https://stacks.cdc.gov/view/cdc/91163/cdc_91163_DS1.pdf
File Type:

No Additional Files

More +

Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline

Details:

Supporting Files

You May Also Like